Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer to pay $400 million to avert investor class action trial
Pfizer to pay $400 million to avert investor class action trial
Pfizer to pay $400 million to avert investor class action trial
Submitted by
admin
on January 27, 2015 - 4:37pm
Source:
Yahoo/Reuters
News Tags:
Pfizer
investors
Class Action Lawsuit
Headline:
Pfizer to pay $400 million to avert investor class action trial
Do Not Allow Advertisers to Use My Personal information
